Bulls Ride Huntsman at 5-Year highs
 

By Mike Yamamoto, managing editor of OptionMonster 

Huntsman  (HUN) has rallied more than 20% in just the last month, and one large investor is going back into the chemical company for even more gains.
 
OptionMonster's tracking systems show that 4,900 October 20 calls were sold for $1.30 while the same number of November 22 calls were bought for 75 cents. Volume was below previous open interest in the October strike but above it in the November contracts, indicating that a long position was rolled forward.
 
The trader is closing the nearer-term position, which expires in about two weeks, and is opening a new one a month later at a higher strike while taking some money off the table in the process. The new long calls are looking for HUN to rally above $22 but will expire worthless if it the stock remains below that strike price through mid-November.
 
Huntsman shares rose 0.48% to $21.13 on Wednesday, their highest close since June 2008.
 
Option traders caught the run early when the stock was below $18 in mid-August. At that time our scanners found buying in the October 18 calls, which tripled a month later when Huntsman bought units of chemical maker Rockwood and was upgraded by Bank of America / Merrill Lynch to "buy" from "neutral" with a $24 price target.
 
Total option volume in Huntsman Wednesday was more than double its daily average for the last month. Only 233 puts changed hands, a reflection of the session's bullish sentiment.
 
Yamamoto has no positions in HUN.
This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

If you liked this article you might like

Wynn Stock Tanks Following Sexual Misconduct Allegations Against CEO

Wynn Stock Tanks Following Sexual Misconduct Allegations Against CEO

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Clariant Shares Edge Higher After CEO Says Open To Working With Activist

Clariant Shares Edge Higher After CEO Says Open To Working With Activist

Airbus, BP and Clariant - Earnings Round-Up

Airbus, BP and Clariant - Earnings Round-Up